tiprankstipranks
Silo Pharma (SILO)
NASDAQ:SILO
US Market

Silo Pharma (SILO) Income Statement

Compare
155 Followers

Silo Pharma Income Statement

Last quarter (Q3 2024), Silo Pharma's total revenue was $18.02K, a decrease of 0.00% from the same quarter last year. In Q3, Silo Pharma's net income was $-928.81K. See Silo Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 72.10K$ 72.10K$ 71.26K$ 40.92K$ 40.57K
Gross Profit
$ 66.26K$ 66.26K$ 66.26K$ -135.20K$ 13.18K
Operating Expenses
$ 3.92M$ 3.71M$ 2.96M$ 2.27M$ 927.64K
Depreciation and Amortization
$ 229.38K$ 72.64K$ -147.29K$ 179.92K$ 28.14K
EBITDA
$ -3.63M$ -3.91M$ 4.19M$ -2.39M$ -930.40K
Operating Income
$ -3.86M$ -3.65M$ -2.74M$ -2.57M$ -930.40K
Other Income/Expenses
$ 224.51K$ -279.73K$ 6.93M$ -464.55K$ -82.89K
Pretax Income
$ -3.63M$ -3.91M$ 4.18M$ -3.04M$ -1.01M
Net Income
$ -3.70M$ -3.91M$ 3.90M$ -3.13M$ -1.05M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.20$ -1.71$ 2.06$ -2.37$ -1.24
Diluted EPS
$ -1.20$ -1.71$ 2.03$ -2.37$ -1.24
Weighted Average Shares Outstanding
3.08M 2.28M 1.90M 1.32M 842.29K
Weighted Average Shares Outstanding (Diluted)
3.08M 2.28M 1.92M 1.32M 842.29K
Currency in USD

Silo Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis